ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.

Lindsey E Roeker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.